感染症分子診断のアメリカ市場

◆英語タイトル:U.S. Infectious Disease Molecular Diagnostics Market 2021: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
◆商品コード:DATA70609085
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2017年6月
◆ページ数:636
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Local PDFUSD6,200 ⇒換算¥682,000見積依頼/購入/質問フォーム
Global PDFUSD13,600 ⇒換算¥1,496,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Complete report $4,350.  DataPack (test volumes, sales forecasts, supplier shares) $2,800.  The report is available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

US Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.

- Five-year test volume and sales projections.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic
  reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular
  diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements
  and new technologies/products in R&D.

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- CellMark Forensics/LabCorp
- Cepheid
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular
  diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 636 pages and 27 tables

【レポートの目次】

http://www.vpgcorp.com/webfiles/DNA/TOCLOT%20USInfectiousDiseaseMolecularDiagnosticsMarket.pdf

http://www.vpgmarketresearch.com/pdffiles/LOTUSInfectiousDiseaseTestingMarket.pdf

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 感染症分子診断のアメリカ市場(U.S. Infectious Disease Molecular Diagnostics Market 2021: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆